Enovis (ENOV) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -24.56% |
| Dec 31, 2025 | -24.42% |
| Oct 3, 2025 | -15.99% |
| Jul 4, 2025 | -9.58% |
| Apr 4, 2025 | -17.37% |
| Dec 31, 2024 | -18.06% |
| Sep 27, 2024 | -10.38% |
| Jun 28, 2024 | -8.91% |
| Mar 29, 2024 | -8.28% |
| Dec 31, 2023 | -1.58% |
| Sep 29, 2023 | -0.15% |
| Jun 30, 2023 | 0.54% |
| Mar 31, 2023 | 1.06% |
| Dec 31, 2022 | -0.38% |
| Sep 30, 2022 | 2.85% |
| Jul 1, 2022 | 2.35% |
| Apr 1, 2022 | 7.47% |
| Dec 31, 2021 | 10.27% |
| Oct 1, 2021 | 10.01% |
| Jul 2, 2021 | 7.15% |
| Apr 2, 2021 | 3.76% |
| Dec 31, 2020 | -1.26% |
| Oct 2, 2020 | 1.57% |
| Jul 3, 2020 | 2.39% |
| Apr 3, 2020 | 3.50% |
| Dec 31, 2019 | 4.10% |
| Sep 27, 2019 | -0.38% |
| Jun 28, 2019 | 3.17% |
| Mar 29, 2019 | 4.92% |
| Dec 31, 2018 | 2.21% |
| Sep 28, 2018 | 1.73% |
| Jun 29, 2018 | 3.19% |
| Mar 30, 2018 | 8.07% |
| Dec 31, 2017 | 3.60% |
| Sep 29, 2017 | -0.27% |
| Jun 30, 2017 | -4.66% |
| Mar 31, 2017 | -3.94% |
| Dec 31, 2016 | 4.11% |
| Sep 30, 2016 | 10.58% |
| Jul 1, 2016 | 11.06% |
| Apr 1, 2016 | 16.20% |
| Dec 31, 2015 | 14.73% |
| Sep 25, 2015 | 19.08% |
| Jun 26, 2015 | 19.58% |
| Mar 27, 2015 | 15.66% |
| Dec 31, 2014 | 160.67% |
| Sep 26, 2014 | 138.41% |
| Jun 27, 2014 | 143.01% |
| Dec 31, 2013 | 133.12% |